Top 10 Clinical Research Organisations in the Pharma and Biotech Industry: Parexel

Parexel is the second largest clinical organization in the world, helping its clients expedite the drug approval process through clinical trials



Adam Muspratt
04/11/2018

Pharma IQ presents the top 10 ranking of Contract Research Organizations as voted by the Pharma IQ network. Click here to see the whole list 

Parexel is the second largest clinical organization in the world, helping its clients expedite the drug approval process through clinical trials. A leading supplier of biopharmaceutical services and expert-based clinical research, the company has a global footprint with 84 facilities in 54 countries, providing a wide array of solutions, including clinical research, consulting, product commercialization, medical communications, and technology for the medical devices, pharmaceuticals and biotechnology sectors.

The company offers services through three different branches, with each branch aligning their goal towards the advancement of the biopharmaceutical and medical device industries to prevent and cure disease.

Clinical Research Services (CRS) – This segment focuses on clinical trials management, data management, observational studies, pharmacovigilance, commercialization and clinical pharmacology.

Parexel Consulting Services (PC) – Parexel has over 30 years of expertise in clinical research and provides a wide array of intelligence-based solutions to its clients in fields such as regulation, drug development, product pricing, communications and market research,

Parexel Informatics (PI) – Parexel’s dedicated informatics sector focuses on providing technology to accelerate the drug development process, with solutions for regulation, patient services, clinical trial supplies & logistics, education and more.

Background

  • The company was founded in 1982 by Josef von Rickenbach and Anne B. Sayigh.

  • In 2017, Parexel was acquired by private equity firm Pamplona Capital in a deal worth $5 billion. Pamplona completed the acquisition by acquiring all outstanding Parexel shares at $88 per share in cash. 

  • In 2018, founder, Josef von Rickenbach stepped down as the CEO after a 35-year tenure, choosing to continue as chairman of the board. The baton was passed to Jamie Macdonald. 

Key information

Headquarters: Waltham, Massachusetts, United States

CEO: Jaime Macdonald – March 2018

Employees: 19,000

Website: www.parexel.com

Estimated revenue: $2.1 B (2017)